Medetomidine: The New Xylazine? What Laboratories Shoul...
At a recent conference, a forensic toxicologist mentions something you h...
Industry Literature
Establishing QC Ranges for New Assays: A Practical Meth...
When Good Assays Fail QC A laboratory validates a new immunoassay, runs ...
Nitazenes: What Labs Need to Know About the Next Wave o...
A forensic toxicologist runs a comprehensive opioid panel on a suspected...
Matrix Effects in LC-MS/MS: A Troubleshooting Guide for...
The instrument passes system suitability. Calibrators look perfect. Your...
Designer Benzodiazepines: The Hidden Challenge in Toxic...
A forensic toxicologist calls with a familiar problem: three overdose de...
Fentanyl Analogues in 2026: A Laboratory Detection Guide
A medical examiner calls with a case that doesn’t add up. The immunoas...
Is Your QC Helping or Hurting Your TDM Patients?
When “Close Enough” Isn’t Good Enough: The Risk to Patient...
UTAK + Santa Clarita Business Journal
The SCV Business Journal gets personal with UTAK and CEO, Jim Plutchak....
Midwest Association for Toxicology and Therapeutic Drug...
The Controls Freaks are sponsoring and attending Midwest Association for...
Find Us on Social
